Genetic Study of Pseudoexfoliation Syndrome
About the Research Project
Program
Award Type
Standard
Award Amount
$69,985
Active Dates
April 01, 2003 - September 30, 2005
Grant ID
G2003027
Summary
Pseudoexfoliation glaucoma is considered the most common identifiable glaucoma in the world. It affects millions of individuals throughout the world and leads to elevated intraocular pressure (IOP), which is associated with the death of optic nerve cells. Pseudoexfoliation material is found throughout many eye and body tissues. Dr. Challa is working to identify the genes involved in pseudoexfoliation syndrome by comparing gene products in people with pseudoexfoliation to the genetics of those without it. He will also compare the gene products between people with pseudoexfoliation who have glaucoma with those who have pseudoexfoliation but no glaucoma. By learning these differences, he hopes to shed light on a possible cause of this disorder, and why some people who have the disorder develop glaucoma while others don’t. With this information, it may be possible to develop new tests and treatments for glaucoma.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
The Immune Landscape of the Human Optic Nerve Head
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Monica Vetter, PhD
Current Organization
University of Utah
The Immune Landscape of the Human Optic Nerve Head
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Monica Vetter, PhD
Current Organization
University of Utah
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute